Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
260 studies found for:    "SARS"
Show Display Options
Rank Status Study
1 Completed Collection of Convalescent SARS Plasma by Apheresis
Conditions: Severe Acute Respiratory Syndrome;   SARS
2 Completed Investigating Severe Acute Respiratory Syndrome (SARS)
Condition: SARS Virus
3 Withdrawn SARS Survivor Evaluations
Condition: Coronavirus (SARS-CoV)
4 Withdrawn Phase I Dose Escalation SARS-CoV Recombinant S Protein, With and Without Adjuvant, Vaccine Study
Condition: SARS
Interventions: Drug: Aluminum hydroxide adjuvant (Alhydrogel®);   Other: Phosphate buffered saline Placebo;   Biological: Recombinant S protein SARS vaccine
5 Withdrawn SARS Coronavirus Vaccine (SARS-CoV)
Condition: Coronavirus (SARS-CoV)
Interventions: Drug: Aluminum hydroxide;   Drug: Placebo;   Biological: SARS-CoV
6 Withdrawn Evaluation and Treatment of Severe Acute Respiratory Syndrome (SARS)
Condition: Severe Acute Respiratory Syndrome
7 Completed Dynamic Profiles of Cytokine/Chemokine in Severe Acute Respiratory Syndrome
Condition: SARS
8 Completed Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR)
Conditions: Allergic Rhinitis;   Hay Fever;   SAR;   Rhinitis, Allergic, Seasonal
Interventions: Drug: Cetirizine;   Drug: Loratadine;   Other: Placebo
9 Completed Study of Alferon® LDO (Low Dose Oral) in Normal Volunteers
Condition: Severe Acute Respiratory Syndrome
Intervention: Drug: Alferon LDO
10 Unknown  A Multi-centre, Double-blinded, Randomized, Placebo-controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir Plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome
Condition: Severe Acute Respiratory Syndrome
Intervention: Drug: Lopinavir / Ritonavir plus Ribavirin
11 Recruiting Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR)
Condition: Seasonal Allergic Rhinitis (SAR)
Interventions: Drug: GSP 301 NS;   Drug: GOM-NS;   Drug: GMM-2 NS;   Drug: GSP 301 placebo NS
12 Recruiting Respiratory Virus Hospitalization Study (FLU 003 Plus)
Conditions: Influenza;   Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV);   Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
13 Completed Phase I Study of a Vaccine for Severe Acute Respiratory Syndrome (SARS)
Condition: Healthy
Interventions: Procedure: Blood Test;   Procedure: Urine Test;   Procedure: Physical Exam;   Drug: Vaccine;   Drug: VRC-SRSDNA015-00-VP
14 Completed A 5-way Treatment Period Trial of Single Doses of Intranasal GSK256066 in Patients With Rhinitis
Conditions: Rhinitis, Allergic, Seasonal;   Seasonal Allergic Rhinitis;   SAR
Intervention: Drug: GSK256066
15 Completed Contamination During Removal of Two Different Personal Protective Systems
Condition: Severe Acute Respiratory Syndrome
Intervention: Procedure: Powered Air purifying respirator
16 Completed Clinical Study of SARS in Children
Condition: Epidemiology
17 Completed
Has Results
Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies
Conditions: Seasonal Allergic Rhinitis;   SAR
Interventions: Drug: BDP HFA;   Drug: Placebo nasal aerosol
18 Active, not recruiting Trial of Pimasertib With SAR245409 or Placebo in Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Pimasertib once daily;   Drug: Pimasertib placebo;   Drug: SAR245409 placebo;   Drug: SAR245409;   Drug: Pimasertib twice daily
19 Completed Seroprevalence of MERS-CoV IgG in Healthcare Workers
Condition: Coronavirus Infections
20 Withdrawn The Interaction Between Severe Acute Respiratory Distress Syndrome Viral Proteins and Monocytes
Condition: Severe Acute Respiratory Syndrome
Intervention: Procedure: blood sampling

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years